RECORD // Company

Silence Therapeutics plc

Built 2026-11-22T03:28:07Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)
Matched by name only, not merged (3)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • Silence Therapeutics GmbH · Ctgov · name equals 'Silence Therapeutics' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • Silence Therapeutics plc · Ctgov · same registered legal name as 'Silence Therapeutics plc' Possible match based on name, not a shared identifier. Compare the records. Compare
  • SILENCE THERAPEUTICS, INC. · Ny corps · name equals 'Silence Therapeutics' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare

6 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-13 · accession 0001193125-26-458896

ItemValuePeriodFormFiledAccessionReport
Revenue$03 months ended 2026-09-3010-Q2026-11-130001193125-26-4588962026-11-22 03:28 UTCReport an error
Net income (loss)$-12,426,0003 months ended 2026-09-3010-Q2026-11-130001193125-26-4588962026-11-22 03:28 UTCReport an error
Cash and cash equivalents$247,659,000at 2026-09-3010-Q2026-11-130001193125-26-4588962026-11-22 03:28 UTCReport an error
Contract liabilities (total)$55,218,000at 2026-09-3010-Q2026-11-130001193125-26-4588962026-11-22 03:28 UTCReport an error
Contract liabilities, current$0at 2026-09-3010-Q2026-11-130001193125-26-4588962026-11-22 03:28 UTCReport an error
Contract liabilities, noncurrent$55,218,000at 2026-09-3010-Q2026-11-130001193125-26-4588962026-11-22 03:28 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001479615
Ticker
SLN
CUSIP
G8128Y157
Record ID
sx:sec:0001479615

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

18 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-16SEC EDGAR company profile2026-11-22 03:28 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-16SEC EDGAR company profile2026-11-22 03:28 UTCReport an error
State of incorporationX02026-11-16SEC EDGAR company profile2026-11-22 03:28 UTCReport an error
Business address12 HAMMERSMITH GROVE, OFFICE 205, LONDON, W6 7AP2026-11-16SEC EDGAR company profile2026-11-22 03:28 UTCReport an error
ExchangesNasdaq, OTC2026-11-16SEC EDGAR company profile2026-11-22 03:28 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$559,0002025-12-3110-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax2026-11-22 03:28 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-88,612,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-22 03:28 UTCReport an error
Total assets (at 2025-12-31)$131,442,0002025-12-3110-K, XBRL Assets2026-11-22 03:28 UTCReport an error
Stockholders' equity (at 2025-12-31)$62,304,0002025-12-3110-K, XBRL StockholdersEquity2026-11-22 03:28 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$11,277,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 03:28 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-62,271,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 03:28 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$55,0002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-22 03:28 UTCReport an error
Operating lease liabilities (at 2025-12-31)$160,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 03:28 UTCReport an error
Form D total offering amount (D filed 2021-02-18)$45,499,9052021-02-18D2026-11-22 03:28 UTCReport an error
Form D total amount sold (D filed 2021-02-18)$45,499,9052021-02-18D2026-11-22 03:28 UTCReport an error
Form D industry groupBiotechnology2021-02-18D2026-11-22 03:28 UTCReport an error
Form D revenue rangeDecline to Disclose2021-02-18D2026-11-22 03:28 UTCReport an error
Form D date of first sale2021-02-042021-02-18D2026-11-22 03:28 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.